TrialFrontiers in oncology2026

Safety and efficacy of PEG-rhG-CSF as primary prophylaxis for neutropenia in gastrointestinal cancer patients receiving combination chemotherapy including oral agents: a prospective, exploratory, non-randomized controlled study.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.